Compare eBay Inc (EBAY) vs Novo Nordisk A/S (NVO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
eBay Inc vs Novo Nordisk A/S — how do they compare? eBay Inc trades at $110.95 (market cap $50.07B), while Novo Nordisk A/S trades at $51.56 (market cap $222.24B). The key difference: Novo Nordisk A/S is far larger — about 4.4× eBay Inc's market cap, and Novo Nordisk A/S pays the higher dividend (3.56%). Which is the better fit depends on your goals.
| EBAY | NVO | |
|---|---|---|
Market Cap | $50.07B | $222.24B |
Volume | 5,186,418 | — |
Sector | Consumer Cyclical | Health |
52-Week High | $118.96 | $71.70 |
52-Week Low | $76.79 | $35.29 |
Enterprise Value | $53.41B | $241.20B |
Dividend Yield | 1.1% | 3.56% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EBAY trades at $111.48, down 0.94% on the day, with a bullish technical signal from moving averages and neutral oscillators. The company reported revenue of $11.10B in 2025 with a net income margin of 17.61%, and has beaten EPS estimates for three consecutive quarters. Recent news highlights eBay's cleared acquisition of Depop and ongoing takeover interest from GameStop.
EBAY presents a mixed outlook with strong profitability and consistent earnings beats offset by high valuation multiples and competitive pressures. The stock's upside potential hinges on successful integration of acquisitions and advertising growth, while risks include market volatility and execution challenges in a dynamic e-commerce landscape.
Novo Nordisk (NVO) trades at $51.52, up 4.99% in the last session, with strong technical momentum and bullish moving averages. The company maintains robust fundamentals, including a 37.2% net income margin and consistent earnings beats in recent quarters. Recent EU approval for the Wegovy weight-loss pill (Reuters, 2026-07-15) reinforces its leadership in GLP-1 therapies, though competition is intensifying.
Outlook remains positive given solid cash flow growth and analyst support, but risks include pricing pressure from generics and slowing prescription trends. The stock's valuation at a P/E of 12.14 offers relative value in the pharma sector, with upside potential if execution continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About eBay Inc
eBay Inc. is a global commerce company. The Company's platforms are designed to enable sellers worldwide to organize and offer their inventory for sale and buyers to find and buy it. eBay's items can be new or used, plain or luxurious, commonplace or rare, trendy or one-of-a-kind.
Read more on EBAY →About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →
